CNIO News -

19.04.2023 Oncologist Richard Vile: “I truly believe that in 10 years’ time oncolytic viruses will be part of effective anti-tumour therapies” Richard Vile is researching oncolytic viruses, which are viruses that specifically attack tumour...

03.04.2023 Claudio Joazeiro: “Our knowledge about protein quality control will lead to new ways to approach cancer, neurodegeneration and aging” Claudio Joazeiro (Brazil, 1968) studies how cells control the quality of their proteins. He wants to...

Scientific News
23.03.2023 A major European project involving CNIO seeks to detect pancreatic cancer in its early stages through a blood test Pancreatic ductal adenocarcinoma (PDAC), the most common type of pancreatic cancer, is usually...

Outreach to Society
23.03.2023 CNIO science at the ‘Madrid es Ciencia’ outreach fair “We do research to prevent, diagnose and treat cancer” is the slogan of the CNIO...

23.03.2023 Gonzalo Aizpurua, Anabel Sáez and Joseph Thomson, awarded with “la Caixa” Foundation fellowships Gonzalo Aizpurua de Arteche, Anabel Sáez Mas and Joseph Thomson, young researchers at the Spanish...

21.03.2023 Tak W. Mak, immunologist: “I am not doing science for recognition” Tak W. Mak (Hong Kong, 1946) is the author of some of the major findings of recent decades on the...

Scientific News
17.03.2023 Scientists identify the mechanisms leading to resistance to lung cancer treatment with Sotorasib, the first KRAS inhibitor According to recent figures published by the Spanish Society of Medical Oncology (SEOM), more than...

16.03.2023 Mariano Barbacid receives the National Research Award: “We discovered the first oncogenes, now more than 500 are known” Mariano Barbacid, head of the Experimental Oncology Group at the CNIO, has been recognized with the...

Scientific News
10.03.2023 CNIO researchers collect samples from cabin crew members to investigate the relationship between cancer and jet lag Our body’s circadian rhythm is “the biological clock that allows us to adapt to an...